Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development

TA McKinsey, R Foo, CG Anene-Nzelu… - Cardiovascular …, 2022 - academic.oup.com
Cardiovascular diseases and specifically heart failure (HF) impact global health and impose
a significant economic burden on society. Despite current advances in standard of care, the …

Role of the epigenome in heart failure

R Papait, S Serio, G Condorelli - Physiological reviews, 2020 - journals.physiology.org
Gene expression is needed for the maintenance of heart function under normal conditions
and in response to stress. Each cell type of the heart has a specific program controlling …

Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation

N Kubo, H Ishii, X Xiong, S Bianco… - Nature structural & …, 2021 - nature.com
The CCCTC-binding factor (CTCF) works together with the cohesin complex to drive the
formation of chromatin loops and topologically associating domains, but its role in gene …

[HTML][HTML] Prdm16 deficiency leads to age-dependent cardiac hypertrophy, adverse remodeling, mitochondrial dysfunction, and heart failure

DM Cibi, KW Bi-Lin, SG Shekeran, R Sandireddy… - Cell reports, 2020 - cell.com
Hypertrophic cardiomyopathy (HCM) is a well-established risk factor for cardiovascular
mortality worldwide. Although hypertrophy is traditionally regarded as an adaptive response …

Genetic Dissection of a Super Enhancer Controlling the Nppa-Nppb Cluster in the Heart

JCK Man, K van Duijvenboden, PHL Krijger… - Circulation …, 2021 - Am Heart Assoc
Rationale: ANP (atrial natriuretic peptide) and BNP (B-type natriuretic peptide), encoded by
the clustered genes Nppa and Nppb, are important prognostic, diagnostic, and therapeutic …

Genomic enhancers in cardiac development and disease

CG Anene-Nzelu, MCJ Lee, WLW Tan… - Nature Reviews …, 2022 - nature.com
Abstract The Human Genome Project marked a major milestone in the scientific community
as it unravelled the~ 3 billion bases that are central to crucial aspects of human life. Despite …

[HTML][HTML] The genetics and epigenetics of ventricular arrhythmias in patients without structural heart disease

M Wang, X Tu - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Ventricular arrhythmia without structural heart disease is an arrhythmic disorder that occurs
in structurally normal heart and no transient or reversible arrhythmia factors, such as …

[HTML][HTML] Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart

DJ Chapski, M Cabaj, M Morselli, RJ Mason… - Journal of molecular and …, 2021 - Elsevier
The temporal nature of chromatin structural changes underpinning pathologic transcription
are poorly understood. We measured chromatin accessibility and DNA methylation to study …

Epigenomes of human hearts reveal new genetic variants relevant for cardiac disease and phenotype

WLW Tan, CG Anene-Nzelu, E Wong, CJM Lee… - Circulation …, 2020 - Am Heart Assoc
Rationale: Identifying genetic markers for heterogeneous complex diseases such as heart
failure is challenging and requires prohibitively large cohort sizes in genome-wide …

[HTML][HTML] The role of selected epigenetic pathways in cardiovascular diseases as a potential therapeutic target

A Wołowiec, Ł Wołowiec, G Grześk, A Jaśniak… - International Journal of …, 2023 - mdpi.com
Epigenetics is a rapidly developing science that has gained a lot of interest in recent years
due to the correlation between characteristic epigenetic marks and cardiovascular diseases …